Royal Fund Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$7.47M |
| 2 |
Kraft Heinz
KHC
|
+$3.46M |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.46M |
| 4 |
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
|
+$1.37M |
| 5 |
First Trust Preferred Securities and Income ETF
FPE
|
+$841K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$6.79M |
| 2 |
GSK
GSK
|
+$3.54M |
| 3 |
PPL
PPL Corp
PPL
|
+$2.33M |
| 4 |
AT&T
T
|
+$968K |
| 5 |
Diageo
DEO
|
+$538K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 15.3% |
| 2 | Technology | 14.94% |
| 3 | Energy | 10.16% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Healthcare | 9.34% |
Similar funds
Royal Fund Management's Q4 2017 Portfolio in Review
As of Q4 2017, Royal Fund Management held 719 positions worth $279M, up 11% from $251M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Royal Fund Management deployed $13.4M of net new capital in Q4 2017, opening 225 new positions and adding to 172 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 ETF: 47,863 shares worth $1.5M.
By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Merck, an estimated $6.79M trimmed.
- Royal Fund Management's largest Q4 2017 buy was State Street SPDR Portfolio S&P 500 ETF: 47,863 shares worth $1.5M.
- Royal Fund Management added most to IBM in Q4 2017, an estimated $7.47M increase.
- Royal Fund Management's biggest Q4 2017 reduction was Merck, cutting an estimated $6.79M.
- Royal Fund Management fully exited iShares US Real Estate ETF in Q4 2017, selling an estimated $104K.
- Royal Fund Management's ten largest holdings make up 34% of its $279M portfolio in Q4 2017.
- Royal Fund Management opened 225 new positions and closed 44 in Q4 2017.
- Royal Fund Management's portfolio value rose 11% quarter-over-quarter to $279M.
Based on Royal Fund Management's 13F filing for Q4 2017, filed 7 May 2020.